fashion -WSS

fashion

author：entertainment 2025-10-01 02:14:46 - browse：4988

Adderall XR capsules are displayed on Feb. 24, 2023. Drug shortages are growing in the United States, and experts see no clear path to resolving them. – health care policy coverage from STAT — Medicare has a new proposal to pay hospitals more to stockpile essential drugs, an effort to avoid shortages of chemotherapies and other drugs. Jenny Kane/AP

WASHINGTON — Medicare has a new proposal to pay hospitals more to stockpile essential drugs — an idea that comes as doctors report running low on critical chemotherapies and other drugs. But experts caution the policy could cause the very shortages that government officials are trying to avoid.

For years most of the solutions for addressing drug shortages have involved giving the Food and Drug Administration more power. During the Covid-19 pandemic, Congress empowered the FDA to make drug companies create backup plans for manufacturing facility interruptions, and to collect information from drug makers on where they source ingredients. The FDA also has the authority to prioritize reviews of applications for drugs in short supply and to prioritize inspections of manufacturing facilities that plan to ramp up production.

But Medicare has its own new idea: paying hospitals to create a “buffer stock” of 86 medicines that HHS deems critical. Medicare would not pay hospitals for the drugs. Rather, it would pay hospitals for the cost of managing a three-month inventory of the drugs. It published the proposal in a rule last week; it’s seeking comment now before it will weigh whether to finalize the policy.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： ER docs worry over extreme heat as a 'mass casualty event'

knowledge

WSS

Humana, CVS hope to turn members into patients at clinics

For BCIs, commercial hurdles may be bigger than scientific ones

Supreme Court strikes down Biden student loan forgiveness program

Here's how to stay safe from wildfire smoke amid reduced air quality

Biden slams SCOTUS affirmative action decision: 'Discrimination still exists in America'

Lilly’s obesity pill cuts 15% of weight at highest dose in mid

entertainment

fashion

hotspot

Hepatitis C has a cure — but many Americans still lack access to it

Belarusian journalist sentenced to 4 years in prison as crackdown continues

Psychedelics group wrestles with new pharma identity

Why do we get seasonal allergies?

Virginia high school admissions case could be legal follow

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

Trump demands the U.S. pay no more for drugs than other countries … again

Illumina to lay off 10% of research and development team

Dobbs anniversary: the lost opportunity of abortion as health care

The simple reason for the increase in autism diagnosis

explore

UnitedHealth starts bidding war with $3.3 billion offer for Amedisys

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

Humana, CVS hope to turn members into patients at clinics

For BCIs, commercial hurdles may be bigger than scientific ones

Nearly two

The drug industry sees a key ally in the Senate prevail

knowledge

Wikipedia

knowledge

focus